• 教授ご挨拶
  • 研究内容
  • メンバー
  • 研究業績
  • Alumni
  • ニュース
  • 募集情報
  • Photos
HOME > 研究業績

研究業績

2017年

  • Priyambada SA, Misaki R, Okamoto T, Okamoto Y, Ohashi T, Ueda K, Matsuura Y, Fujiyama K. "Cell surface N-glycan alteration in HepAD38 cell lines expressing Hepatitis B virus" Virus Res. Jun 20;238:101-109 2017. doi: 10.1016/j.virusres.2017.06.003. [Epub ahead of print]
  • Honda T, Sofuku K, Kojima S, Yamamoto Y, Ohtaki N, Tomonaga K. "Linkage between the leader sequence and leader RNA production in Borna disease virus-infected cells." Virology Jul 14;510:104-110 2017
  • Honda T, Sofuku K, Matsunaga H, Tachibana M, Mohri I, Taniike M, Tomonaga K. "Detection of Antibodies against Borna Disease Virus Proteins in an Autistic Child and Her Mother" Jpn J Infect Dis. Mar 24;70(2):225-227 2017
  • Tokunaga T, Yamamoto Y, Sakai M, Tomonaga K, Honda T. "Antiviral activity of Favipiravir (T-705) against mammalian and avian bornaviruses" Antiviral Res. Apr 29;143:237-245 2017
  • Hossain MG, Ueda K. "Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity" PLoS One. Jan 3;12(1):e0167871 doi:10.1371/journal.pone.0167871 2017
  • Ohsaki E, Ueda K. "A chimeric protein composed of NuMA fused to the DNA binding domain of LANA is sufficient for the ori-P-dependent DNA replication" Virology. Jan;500:190-197 2017

2016年

  • Tanaka T, Okuyama-Dobashi K, Murakami S, Chen W, Okamoto T, Ueda K, Hosoya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M, Moriishi K. "Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation" Antiviral Res. Sep;133:156-64 2016
  • Osawa M, Mine S, Ota S, Kato K, Sekizuka T, Kuroda M, Kataoka M, Fukumoto H, Sato Y, Kanno T, Hasegawa H, Ueda K, Fukayama M, Maeda T, Kanoh S, Kawana A, Fujikura Y, Katano H. "Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi's sarcoma-associated herpesvirus" Infect Agent Cancer. Aug 17;11:37 2016
  • Somiya M, Liu Q, Yoshimoto N, Iijima M, Tatematsu K, Nakai T, Okajima T, Kuroki K, Ueda K, Kuroda S. "Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan" Virology Jul 12;497:23-32 2016
  • Takamatsu S, Shimomura M, Kamada Y, Maeda H, Sobajima T, Hikita H, Iijima M, Okamoto Y, Misaki R, Fujiyama K, Nagamori S, Kanai Y, Takehara T, Ueda K, Kuroda S, Miyoshi E. "Core-fucosylation plays a pivotal role in hepatitis B pseudo virus infection: a possible implication for HBV glyco-therapy" Glycobiology Jun 21. pii: cww067 2016
  • Honda T. "Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma" Front Chem. 4:21 2016
  • Rahayu R, Ohsaki E, Omori H, Ueda K. " Localization of Latency-Associated Nuclear Antigen (LANA) On Mitotic Chromosomes" Virology May 30;496:51-58 2016
  • 本田知之、朝長啓造
    「内在性RNAウイルスエレメントによるウイルスRNA制御仮説」 ウイルス 66(1):39-46 2016

2015年

  • Ueda K. "HBV; genes and replication" Nihon Rinsho. Dec;73 Suppl 9:349-56 2015
  • Kanno T, Uehara T, Osawa M, Fukumoto H, Mine S, Ueda K, Hasegawa H, Katano H. "Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells" Biochem Biophys Res Comm. Aug 7;463(4):1267-72. doi:10.1016/j.bbrc.2015.06.100. 2015
  • Zheng X, Ohsaki E, Ueda, K. "Mechanism of angiopoietin-1 upregulation in Kaposi's sarcoma-associated herpesvirus-infected PEL cell lines"J Virol. May;89(9):4786-97 doi: 10.1128/JVI.03144-14 2015
  • Ohsaki E and Ueda K. "The intracellular dynamics of lytic replication components and the lytic origin of Kaposi’s sarcoma-associated herpesvirus" Annals of Virol. 1(1):1003 2015
  • 上田啓次
    「ヘルペスウイルス8型とEBウイルスの重感染」高田賢蔵監修、柳井秀雄、清水則夫、吉山裕規編 EBウイルス(改訂第3版)pp70-75 2015
  • 上田啓次
    「肝炎ウイルスレセプター」ウイルス肝炎・肝癌研究の新展開 細胞 47(11):8-11, 2015

2014年

  • Ueda K. "Change in Cellular Gene Expression by hepatitis B virus (HBV)" 219-232. Epidemiology I - Theory, Research and Practice. iConcept 2014
  • Ueda K and Omori H. "Successful Generation of Hepatitis B virus (HBV) Pseudotype Particle; a versatile tool for Identification of the HBV Receptor and Investigation of HBV infectivity" J. Liver. doi.org/10.4172/2167-0889.1000169. 2014
  • 上田啓次
    「DNAウイルス」病原微生物学 pp167-179 東京化学同人 2014
  • 上田啓次
    「ウイルスの感染機構」pp234−243 プログレッシブ生命科学 南山堂 2014
  • 上田啓次
    「細菌の感染機構 pp244-249 プログレッシブ生命科学 南山堂 2014

2013年

  • Ueda K. "Start or End? ; one of the biggest mysteries is finally solved?" Medical Microbiology and Diagnosis dx.doi.org/10.4172/2165-7866.1000e101, 2013
  • Ueda K. "One year passed since a bile acid transporter (sodium taurocholate cotranspoting peptide [NTCP] was nominated as a hepatitis B virus (HBV) entry receptor; has the NTCP has been as a real HBV receptor?" Medical Microbiology and Diagnosis. 1000e102, 2013
  • 上田啓次
    「HBV遺伝子と関連抗原」 Hepatology Practice. pp2-9. 文光堂 2013
  • 上田啓次
    「グルココルチコイド感受性領域」 Hepatology Practice. pp149-151. 文光堂 2013

2012年

  • Ueda K. "Kaposi's Sarcoma-associated Herpesvirus Induced Tumorigenesis; how viral oncogenic Insults are Evaded." J.Blood and Lymph 2:3, 2012. doi.org/10.4172/2165-7831.1000e109.
  • Ueda K. "For the future studies of Kaposi's sarcoma-associated herpesvirus". An Editorial. Frontiers in Virology 3: 1-2, 2012. doi: 10.3389/fmicb.2012.00237.
  • Noma S, Ohya-Shimada W, Kanai M, Ueda K, Nakamura T, Funakoshi H. "Overexpression of HGF attenuates the degeneration of Purkinje cells and Bergmann glia in a knockin mouse model of spinocerebellar ataxia type 7." Neuroscience Res. 73(2):115-21. 10.1016/j.neures.2012.03.001.
  • Ueda K, Ito E, Karayama M, Ohsaki E, Nakano K and Watanabe S. "Kaposi's sarcoma-associated Virus governs gene expression profiles toward B cell transformation." In "Herpesviruses", Magel, D. G. and Tyring, S., ed., In-Tech ISBN 978-953-51-0186--4. 93-104, 2012
  • Nakano K, Katano H, Tadagaki K, Sato Y, Ohsaki E, Mori Y, Yamanishi K, Ueda K. "Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II" Virology. Apr 10;425(2):95-102 2012. doi: 10.1016/j.virol.2012.01.008.
  • Ohsaki E, Ueda K. "Kaposi's Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency." Front Microbiol. (3)-12 2012
  • Ohnishi H, Oka K, Mizuno S and Nakamura T. "Identification of mannose receptor as a receptor for HGF β-chain: A novel ligand-receptor pathway for enhancing macrophage phagocytosis" J Biol Chem, 287: 13371-13381 2012
  • 上田啓次
    遺伝子挿入HBVを用いた感染リセプターの探索.肝胆膵 65:601−609、2012
  • 上田啓次
    B型肝炎のウイルス学.化学療法の領域 48:125-133, 2012

2011年

  • Ueda K, Ohsaki E, Nakano K and Zheng X. "Characterization of Kaposi's sarcoma-associated virus-associated lymphomas by DNA array analysis." In "Leukemia Research and Diagnosis in the Era of High-throughput Genome Analysis (LRD). Leukemia Research and Treatment, p1-11,2011

2010年

  • Isegawa Y, Matsumoto C, Nishinaka K, Nakano K, Tanaka T, Sugimoto N, and Ohshima A. "PCR with quenching probes enables the rapid detetion and identification of ganciclovir-resistance-causing U69 gene mutations in human herpesvirus 6." Mol Cell Probes. 24(4): 167-177, 2010
  • Ueda K, Ito E, Karayama, M., Ohsaki, E., Nakano, K., and Watanabe, S. "KSHV infected PEL cell lines exhibit a distinct gene expression profile." Biochem Biophys Res Commun. 394(3): 482-487, 2010
  • Suzuki T, Isobe T, Kitagawa M and Ueda K. "Kaposi's sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53." Biochem. Biophsys. Res. Comm. 403: 194-197, 2010
  • 上田啓次
    ヘルペスウイルス学のエッセンス 化学療法の領域 26:265-270, 2010
  • 上田啓次
    STEALTHING, PERSISTINGウイルスの謎「潜伏感染と再活性化」化学療法の領域.上田啓次(企画)26:1178-1179, 2010
  • 上田啓次
    カポジ肉腫関連ヘルペスウイルス(KSHV)の潜伏感染、再活性化と病態.化学療法の領域 26:1218-1226, 2010
  • 上田啓次
    B型肝炎ウイルスレセプターの謎.Hepatoday No.23, 12, 2010

2009年

  • Ohsaki E, Karayama M and Ueda K. "Accumulation of LANA at Nuclear Matrix is important for Kaposi's sarcoma Associated Herpesvirus Replication in Latency." Virus Research, 139:74-84, 2009
  • Kamimoto M, Mizuno S, Matsumoto K and Nakamura T. Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase dependent mechanism. Biochem Biophys Res Communs, 380:333-337, 2009
ページの先頭へ